- Exchange: Tel Aviv
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Vaxil Bio Ltd+ Add to Watchlist
VAXL:IT49.90 ILs 4.50 9.91%
As of 10:24:12 ET on 01/27/2015.
Company Profile for Vaxil Bio Ltd (VAXL)
Vaxil Bio Limited is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology.
Vaxil Bio Ltd
Key Executives for Vaxil Bio Ltd (VAXL)
|Lior CarmonFounder/CEO/Head:Research||Julian LevyPresident/CFO|
|Riva KovjazinDirector:Research||Ofira MoranClinical Trials Monitoring|